Skip to main content
NIH funding notice RFA-DE-23-010

The Role of Dentistry in the Prevention of Opioid Drug Misuse and Abuse (UG3/UH3 Clinical Trial Optional)

Closed on May 10, 2022.

Posted
March 2, 2022
Close date
May 10, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$580,179
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF KENTUCKY1

Most frequent study sections

  1. Special Emphasis Panel (ZDE1 YM (06))1
1 award under RFA-DE-23-010 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2023Empowering dentists to reduce opioid prescriptions to young people1UG3DE032621-01Oyler, DouglasRojas Ramirez, Marcia VanessaUNIVERSITY OF KENTUCKY, KYFirst-year cost $580,179Study section ZDE1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-DE-23-010: The Role of Dentistry in the Prevention of Opioid Drug Misuse and Abuse (UG3/UH3 Clinical Trial Optional) | ScienceDex | ConductScience